Boris Karanović
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Papers in
-
- COVID-19 Clinical Research Studies 5
- Genetics 3
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3
- Co-authors
- Marko Barešić (5 shared papers)Branimir Anić (6 shared papers)Sergio A. Mezzano (1 shared paper)Marisa Di Natale (1 shared paper)Fernando Anaya (1 shared paper)Srđan Novak (3 shared papers)Manuel Arias (1 shared paper)Manel Perelló (1 shared paper)
In The Last Decade
Boris Karanović
12 papers receiving 340 citations
Peers
Comparison fields: 5 of 30
- Infectious Diseases 231
- Rheumatology 86
- Modeling and Simulation 8
- Dermatology 12
- Pulmonary and Respiratory Medicine 33
Countries citing papers authored by Boris Karanović
This map shows the geographic impact of Boris Karanović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Karanović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Karanović more than expected).
Fields of papers citing papers by Boris Karanović
This network shows the impact of papers produced by Boris Karanović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Karanović. The network helps show where Boris Karanović may publish in the future.
Co-authors
The 20 scholars most cited alongside Boris Karanović, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 176 | |
| 2 | 2021 | 97 | |
| 3 | 2021 | 40 | |
| 4 | 2022 | 13 | |
| 5 | 2020 | 11 | |
| 6 | 2023 | 6 | |
| 7 | 2022 | 4 | |
| 8 | [Guidelines for the diagnosis and treatment of hereditary angioedema]. | 2015 | 2 |
| 9 | 2023 | 2 | |
| 10 | 2023 | 2 | |
| 11 | Misleading symptoms of hereditary angioedema type II mimicking familial mediterranean fever. | 2021 | 1 |
| 12 | 2025 | 1 | |
| 13 | 2026 | 0 |
About Boris Karanović
Boris Karanović is a scholar working on Infectious Diseases, Genetics, Rheumatology, Pathology and Forensic Medicine and Modeling and Simulation, having authored 13 papers that have together received 355 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Systemic Sclerosis and Related Diseases (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), COVID-19 epidemiological studies (1 paper), Ocular Diseases and Behçet’s Syndrome (1 paper), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Infectious Diseases (231 citations), Rheumatology (86 citations), Modeling and Simulation (8 citations), Dermatology (12 citations) and Pulmonary and Respiratory Medicine (33 citations). Boris Karanović has collaborated with scholars based in Croatia, Spain and Chile. Frequent co-authors include Marko Barešić, Branimir Anić, Sergio A. Mezzano, Marisa Di Natale, Fernando Anaya, Srđan Novak, Manuel Arias, Manel Perelló, Elizabeth Sarmiento and Javier Carbone. Their work appears in journals such as The Lancet Rheumatology, JAMA Network Open, Clinical Rheumatology, Lara D. Veeken and Journal of Personalized Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.